KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biogen (BIIB) Net Margin (2016 - 2025)

Historic Net Margin for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to 2.15%.

  • Biogen's Net Margin fell 130100.0% to 2.15% in Q4 2025 from the same period last year, while for Dec 2025 it was 13.07%, marking a year-over-year decrease of 38000.0%. This contributed to the annual value of 13.07% for FY2025, which is 38000.0% down from last year.
  • Biogen's Net Margin amounted to 2.15% in Q4 2025, which was down 130100.0% from 18.4% recorded in Q3 2025.
  • Biogen's 5-year Net Margin high stood at 45.59% for Q3 2022, and its period low was 4.85% during Q3 2021.
  • Moreover, its 5-year median value for Net Margin was 16.26% (2021), whereas its average is 15.56%.
  • Per our database at Business Quant, Biogen's Net Margin soared by 504400bps in 2022 and then crashed by -481300bps in 2023.
  • Over the past 5 years, Biogen's Net Margin (Quarter) stood at 3.72% in 2021, then soared by 691bps to 21.97% in 2022, then tumbled by -53bps to 10.43% in 2023, then increased by 4bps to 10.86% in 2024, then crashed by -120bps to 2.15% in 2025.
  • Its last three reported values are 2.15% in Q4 2025, 18.4% for Q3 2025, and 24.0% during Q2 2025.